CN103800671B - A kind of Chinese medicine preparation for the treatment of aphtha - Google Patents
A kind of Chinese medicine preparation for the treatment of aphtha Download PDFInfo
- Publication number
- CN103800671B CN103800671B CN201410046747.0A CN201410046747A CN103800671B CN 103800671 B CN103800671 B CN 103800671B CN 201410046747 A CN201410046747 A CN 201410046747A CN 103800671 B CN103800671 B CN 103800671B
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- aphtha
- chinese medicine
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine preparation for the treatment of aphtha, be made up of Radix Angelicae Sinensis, Rhizoma Coptidis, Radix Rehmanniae, Cortex Moutan, Gypsum Fibrosum, the Rhizoma Anemarrhenae, Radix Ophiopogonis, Cortex Phellodendri, Rhizoma Polygonati Odorati, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Radix Et Rhizoma Rhei, drug ratio used is reasonable, immunity of organisms can be improved, promote ulcer surface healing, good effect, side effect is little, does not recur.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation, especially relate to a kind of Chinese medicine preparation for the treatment of aphtha.
Background technology
Aphtha is a kind of disease that in the disease of cari oris mucosa, sickness rate is the highest, and common cold, dyspepsia, psychentonia, the gloomy situation such as discomfort all can cause the generation of this disease, are apt to occur in lip, cheek, lingual margin etc., all can occur at any position of mucosa.Light-duty recurrent aphtha is responsive from the beginning of lesion or occur needle point sample size or slightly large congested district, namely diameter is formed in a short time at about 2 ~ 4mm circle or elliptical boundary shallow aphtha clearly, can spontaneous recovery gradually through about 7 ~ 10 days ulcer, do not stay cicatrix, but can recur again after the intermission different in size, patient is very painful.The heavy recurrent aphtha course of disease be everlasting the moon remaining more than, leave over cicatrix more afterwards, severe patient can formative tissue defect or deformity.At present, treatment aphtha mainly contains topical therapeutic and whole body therapeutic, and topical therapeutic main purpose is antiinflammatory, pain relieving, promote ulcer healing, as gargarism: 0.25% chlortetracycline solution, 1:5000 hibitane liquor hibitane, 1:5000 potassium permanganate solution, 1:5000 furacilin solution etc.Whole body therapeutic has immunosuppressant, immunomodulator and reinforcing agent, and side effect is large, easily recurs, unsuitable life-time service.
Summary of the invention
The object of the invention is: the Chinese medicine preparation of the treatment aphtha providing a kind of good effect, side effect little.
Technical scheme of the present invention is: a kind of Chinese medicine preparation for the treatment of aphtha, is made up of following medicine by weight percentage: Radix Angelicae Sinensis 8-12%, Rhizoma Coptidis 4-6%, Radix Rehmanniae 8-12%, Cortex Moutan 6-8%, Gypsum Fibrosum 13-17%, Rhizoma Anemarrhenae 7-9%, Radix Ophiopogonis 4-6%, Cortex Phellodendri 4-6%, Rhizoma Polygonati Odorati 8-12%, Rhizoma Chuanxiong 8-12%, Radix Paeoniae Rubra 8-12%, Radix Et Rhizoma Rhei 4-6%.
Further preferably, treat a Chinese medicine preparation for aphtha, be made up of following medicine by weight percentage: Radix Angelicae Sinensis 10%, Rhizoma Coptidis 5%, Radix Rehmanniae 10%, Cortex Moutan 7%, Gypsum Fibrosum 15%, the Rhizoma Anemarrhenae 8%, Radix Ophiopogonis 5%, Cortex Phellodendri 5%, Rhizoma Polygonati Odorati 10%, Rhizoma Chuanxiong 10%, Radix Paeoniae Rubra 10%, Radix Et Rhizoma Rhei 5%.
The invention has the beneficial effects as follows: in the present invention, Radix Angelicae Sinensis has to enrich blood invigorates blood circulation, menstruction regulating and pain relieving, effect of loosening bowel to relieve constipation, for rheumatic arthralgia, and ulcer sores; Rhizoma Coptidis has heat clearing and damp drying, effect of eliminating fire and detoxication, has antimicrobial and protozoacide effect, for hyperactivity of heart-fire, and dysphoria and insomnia, heat in blood tells nosebleed, conjunctival congestion, and toothache, quenches one's thirst, carbuncle furuncle; Radix Rehmanniae has clearing away heat and promoting production of body fluid, removing heat from blood, effect of hemostasis, and for consumption of YIN caused by febrile disease, crimson tongue excessive thirst, sends out speckle dermexanthesis, spits blood, epistaxis, laryngopharynx swelling and pain; Cortex Moutan has antibacterial action, has clearing away heat and cooling blood, effect of blood circulation promoting and blood stasis dispelling, for maculae caused by violent heat pathogen, and hematemesis and epistaxis, carbuncle sore tumefacting virus; Gypsum Fibrosum has clearing away heat-fire, effect that relieving restlessness is quenched the thirst; The Rhizoma Anemarrhenae has clearing away heat-fire, and effect of moisturizing of promoting the production of body fluid, has collaborative effect with Gypsum Fibrosum compatibility, can strengthen the clearing away heat-fire effect of Gypsum Fibrosum; Radix Ophiopogonis calls Radix Ophiopogonis, has YIN nourishing and the production of body fluid promoting, effect that lung moistening clears away heart-fire, and for dryness of the lung dry cough, Tianjin wound is thirsty, vexed insomnia, and interior-heat is quenched one's thirst, dryness of the intestine constipation; Cortex Phellodendri has heat clearing and damp drying, and pathogenic fire purging removes steams, effect of detoxification sore treatment, for hyperactivity of fire caused by deficiency of YIN, and night sweat hectic fever due to YIN-deficiency; Rhizoma Polygonati Odorati has nourishing YIN to relieve dryness, effect of promoting the production of body fluid to quench thirst, for lung stomach-Yin wound, and cough caused by dryness-heat, dry throat and mouth, interior-heat is quenched one's thirst; Rhizoma Chuanxiong has blood-activating and qi-promoting, effect of wind-expelling pain-stopping, for lump in the abdomen stomachache, and the twinge of the breast side of body, tumbling and swelling, rheumatic arthralgia; Radix Paeoniae Rubra has clearing away heat and cooling blood, effect of eliminating stasis to stop pain, for maculae caused by violent heat pathogen, and hematemesis and epistaxis, conjunctival congestion and swelling pain, hypochondriac pain due to stagnation of liverQI, lump in the abdomen is suffered from abdominal pain, carbuncle skin infection; Radix Et Rhizoma Rhei has purging heat and dredging bowels, removing pathogenic heat from blood and toxic substance from the body, effect of eliminating blood stasis and inducing menstruation, and for excess-heat constipation, stagnant stomachache, dysentery is not well, jaundice due to damp-heat, and heat in blood tells nosebleed, conjunctival congestion, pharyngeal swelling, abdominalgia with intestinal abscess, carbuncle furuncle.The present invention is pure Chinese medicinal preparation, and drug ratio used is reasonable, can improve immunity of organisms, and promote ulcer surface healing, good effect, side effect is little, does not recur.
Detailed description of the invention
Treat a Chinese medicine preparation for aphtha, be made up of following medicine by weight percentage: Radix Angelicae Sinensis 8-12%, Rhizoma Coptidis 4-6%, Radix Rehmanniae 8-12%, Cortex Moutan 6-8%, Gypsum Fibrosum 13-17%, Rhizoma Anemarrhenae 7-9%, Radix Ophiopogonis 4-6%, Cortex Phellodendri 4-6%, Rhizoma Polygonati Odorati 8-12%, Rhizoma Chuanxiong 8-12%, Radix Paeoniae Rubra 8-12%, Radix Et Rhizoma Rhei 4-6%.
Using method of the present invention: the above medicine of proportioning (except Radix Et Rhizoma Rhei, Radix Et Rhizoma Rhei steeps separately, and water is put into after opening) is combined, water is appropriate, soaks 1 to 2 hours with clear water; Steady fire boils and boils, and puts into Radix Et Rhizoma Rhei, and water boils 20 to 30 minutes after opening again; Medicinal liquid is leached with gauze; One day one clothes 7 to 10 days are a course for the treatment of.
Embodiment 1:
Treat a Chinese medicine preparation for aphtha, be made up of following medicine by weight percentage: Radix Angelicae Sinensis 10%, Rhizoma Coptidis 5%, Radix Rehmanniae 10%, Cortex Moutan 7%, Gypsum Fibrosum 15%, the Rhizoma Anemarrhenae 8%, Radix Ophiopogonis 5%, Cortex Phellodendri 5%, Rhizoma Polygonati Odorati 10%, Rhizoma Chuanxiong 10%, Radix Paeoniae Rubra 10%, Radix Et Rhizoma Rhei 5%.Using method: the above medicine of proportioning (except Radix Et Rhizoma Rhei, Radix Et Rhizoma Rhei steeps separately, and water is put into after opening) is combined, water is appropriate, soaks 1 to 2 hours with clear water; Steady fire boils and boils, and puts into Radix Et Rhizoma Rhei, and water boils 20 to 30 minutes after opening again; Medicinal liquid is leached with gauze; One day one clothes 7 to 10 days are a course for the treatment of.
Embodiment 2:
Treat a Chinese medicine preparation for aphtha, be made up of following medicine by weight percentage: Radix Angelicae Sinensis 8%, Rhizoma Coptidis 4%, Radix Rehmanniae 12%, Cortex Moutan 8%, Gypsum Fibrosum 15%, the Rhizoma Anemarrhenae 9%, Radix Ophiopogonis 4%, Cortex Phellodendri 6%, Rhizoma Polygonati Odorati 8%, Rhizoma Chuanxiong 12%, Radix Paeoniae Rubra 8%, Radix Et Rhizoma Rhei 6%.Using method is with embodiment 1.
Embodiment 3:
Treat a Chinese medicine preparation for aphtha, be made up of following medicine by weight percentage: Radix Angelicae Sinensis 12%, Rhizoma Coptidis 6%, Radix Rehmanniae 8%, Cortex Moutan 6%, Gypsum Fibrosum 15%, the Rhizoma Anemarrhenae 7%, Radix Ophiopogonis 6%, Cortex Phellodendri 4%, Rhizoma Polygonati Odorati 12%, Rhizoma Chuanxiong 8%, Radix Paeoniae Rubra 12%, Radix Et Rhizoma Rhei 4%.Using method is with embodiment 1.
Embodiment 4:
Treat a Chinese medicine preparation for aphtha, be made up of following medicine by weight percentage: Radix Angelicae Sinensis 9%, Rhizoma Coptidis 5%, Radix Rehmanniae 9%, Cortex Moutan 7%, Gypsum Fibrosum 17%, the Rhizoma Anemarrhenae 8%, Radix Ophiopogonis 5%, Cortex Phellodendri 5%, Rhizoma Polygonati Odorati 9%, Rhizoma Chuanxiong 11%, Radix Paeoniae Rubra 10%, Radix Et Rhizoma Rhei 5%.Using method is with embodiment 1.
Embodiment 5:
Treat a Chinese medicine preparation for aphtha, be made up of following medicine by weight percentage: Radix Angelicae Sinensis 11%, Rhizoma Coptidis 4%, Radix Rehmanniae 11%, Cortex Moutan 7%, Gypsum Fibrosum 13%, the Rhizoma Anemarrhenae 9%, Radix Ophiopogonis 6%, Cortex Phellodendri 6%, Rhizoma Polygonati Odorati 11%, Rhizoma Chuanxiong 9%, Radix Paeoniae Rubra 8%, Radix Et Rhizoma Rhei 5%.Using method is with embodiment 1.
Claims (2)
1. treat the Chinese medicine preparation of aphtha for one kind, it is characterized in that, be made up of following medicine by weight percentage: Radix Angelicae Sinensis 8-12%, Rhizoma Coptidis 4-6%, Radix Rehmanniae 8-12%, Cortex Moutan 6-8%, Gypsum Fibrosum 13-17%, Rhizoma Anemarrhenae 7-9%, Radix Ophiopogonis 4-6%, Cortex Phellodendri 4-6%, Rhizoma Polygonati Odorati 8-12%, Rhizoma Chuanxiong 8-12%, Radix Paeoniae Rubra 8-12%, Radix Et Rhizoma Rhei 4-6%.
2. the Chinese medicine preparation for the treatment of aphtha according to claim 1, it is characterized in that, be made up of following medicine by weight percentage: Radix Angelicae Sinensis 10%, Rhizoma Coptidis 5%, Radix Rehmanniae 10%, Cortex Moutan 7%, Gypsum Fibrosum 15%, the Rhizoma Anemarrhenae 8%, Radix Ophiopogonis 5%, Cortex Phellodendri 5%, Rhizoma Polygonati Odorati 10%, Rhizoma Chuanxiong 10%, Radix Paeoniae Rubra 10%, Radix Et Rhizoma Rhei 5%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410046747.0A CN103800671B (en) | 2014-02-11 | 2014-02-11 | A kind of Chinese medicine preparation for the treatment of aphtha |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410046747.0A CN103800671B (en) | 2014-02-11 | 2014-02-11 | A kind of Chinese medicine preparation for the treatment of aphtha |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103800671A CN103800671A (en) | 2014-05-21 |
CN103800671B true CN103800671B (en) | 2016-02-10 |
Family
ID=50698366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410046747.0A Expired - Fee Related CN103800671B (en) | 2014-02-11 | 2014-02-11 | A kind of Chinese medicine preparation for the treatment of aphtha |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103800671B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1264375A (en) * | 1997-07-18 | 2000-08-23 | 诺瓦提斯公司 | Crystal modification of N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
-
2014
- 2014-02-11 CN CN201410046747.0A patent/CN103800671B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1264375A (en) * | 1997-07-18 | 2000-08-23 | 诺瓦提斯公司 | Crystal modification of N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
Non-Patent Citations (1)
Title |
---|
中医药治疗复发性口腔溃疡;张龙娥;《实用中医内科杂志》;20131231;第27卷(第5期);第162页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103800671A (en) | 2014-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103800686B (en) | A kind of medicine for the treatment of acute radiodermatitis | |
CN104524337A (en) | Traditional Chinese medicine for treating dental ulcer | |
CN106620392A (en) | Crab louse-removing lotion | |
CN103520530B (en) | Medicament for treating erysipelas and preparation method thereof | |
CN101129672A (en) | Orally taken traditional Chinese medicine composition for treating bacillary dysentery | |
CN102018907B (en) | Medicine for treating fever in children and preparation method thereof | |
CN106075359A (en) | A kind of Chinese medicine composition treating fungi type tinea pedis | |
CN105362847A (en) | Traditional Chinese medicine composition for wound care | |
CN105106756A (en) | Traditional Chinese medicine composition for treating age pigment | |
CN103784796A (en) | Chinese medicinal preparation for treating simple goiter | |
CN103800671B (en) | A kind of Chinese medicine preparation for the treatment of aphtha | |
CN103610934B (en) | A kind of Chinese medicine for the treatment of pharyngitis | |
CN102688418B (en) | Traditional Chinese medicine composition for treating night sweat | |
CN105395890A (en) | Traditional Chinese medicine preparation used for treating extensor carpi tenosynovitis | |
CN101361940A (en) | Mammary gland rehabilitation medicine plaster | |
CN104107344A (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
CN104225569A (en) | Chinese medicinal composition for treating chronic enteritis | |
CN104225382A (en) | Traditional Chinese medicine for treatment of pimples | |
CN102961605B (en) | Traditional Chinese medicine composition for treating alopecia seborrhoeica | |
CN104491228A (en) | Traditional Chinese medicine composition for treating kidney yang deficiency type retention of urine | |
CN105250807A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
CN104771663A (en) | Traditional Chinese medicine composition for removing acne mark and preparation method thereof | |
CN104107374A (en) | Traditional Chinese medicine capsule for treating cervical erosion and preparation method of traditional Chinese medicine capsule | |
CN104189462A (en) | Traditional Chinese medicine composition for treating acne | |
CN104258130A (en) | Traditional Chinese medicinal preparation for treating chronic urticaria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160210 Termination date: 20170211 |